Home
Products
Services
Applications
Resource Center
Ordering
About Exiqon
Investor
Products
microRNA Research
RNA Isolation
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Research
RNA Preparation
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
DNA Research
SNP Detection
Microarray Analysis
In Situ Hybridization
Custom Oligos
Other Reagents
LNA Phosphoramidites
AQ-link Products
A2 Quencher
Services
RNA Isolation Services
microRNA Array Services
microRNA PCR Services
microRNA ISH Services
Applications
Isolation
RNA
Microarray Analysis
microRNA
RNA
DNA
Northern Blotting
microRNA
Real-time PCR
microRNA
mRNA
In Situ Hybridization
microRNA
Other RNAs
DNA
Functional Analysis
microRNA
RNA
SNP Detection
DNA
Resource Center
MicroRNA Research
Research Guide
Array Downloads
qPCR Data Analysis
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
RNA Research
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Other reagents
Technical Literature and Manuals
Scientific Publications
Technology Base
Oligo modifications
LNA™
AQ-link
Oligo design tools
Exiqon E-talk
Ordering
Order microRNA products
Order custom oligos
Distributors
General Information
About Exiqon
Contact
Company profile
Sign up to Newsletter
Newsletter Back Issues
Investor
Investor Relations
Share Info
Calendar
Reports
Figures
Analysts
Presentations
Contact
Announcements
Financials
Guidelines for IP
Corporate Gov.
IR Policy
Articles of Association
Contact Us
microRNA Research
RNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
AQ-link Products
A2 Quencher
RNA Isolation Services
microRNA Array Services
microRNA PCR Services
microRNA ISH Services
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
mRNA
microRNA
Other RNAs
DNA
microRNA
RNA
DNA
MicroRNA Research
RNA Research
Other reagents
Technology Base
Oligo design tools
Exiqon E-talk
Research Guide
Array Downloads
qPCR Data Analysis
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
General Information
Contact
Company profile
Sign up to Newsletter
Newsletter Back Issues
Investor Relations
Announcements
Financials
Guidelines for IP
Corporate Gov.
Contact Us
Share Info
Calendar
Reports
Figures
Analysts
Presentations
Contact
IR Policy
Articles of Association
Welcome to Exiqon's Investor Site
Exiqon maintains an open and continuous dialogue with existing and potential shareholders, stakeholders and the general public. We aim for a high degree of openness and we are committed to communicating information in compliance with the disclosure requirements of the NASDAQ OMX Copenhagen A/S.
Exiqon publishes quarterly reports on the company's development, including relevant financial information. In addition, we will publish details about the company where such information is considered important to the pricing of its shares. Exiqon maintains an insider register and will publish any changes to certain insiders' shareholdings in accordance with the rules that apply for NASDAQ OMX Copenhagen A/S. Any such publication will be made immediately after the transaction. We have adopted in-house rules that only allow insiders to purchase and sell shares in Exiqon A/S during a 28 day period after the company's publication of interim financial statements. Such information will first be published via the websites of the NASDAQ OMX in Copenhagen (www.omxnordicexchange.com) and will immediately thereafter be available here on our website. Shareholders and others who via our website have requested the receipt of e-mail news from the Exiqon, will receive the information immediately thereafter.
We respect the principle of equal treatment of all market players to ensure fair pricing of the Exiqon's shares.
Latest share info
Supplied by NASDAQ OMX
Recent Annual Reports
 
2009
 
2009 - UK
 
2009 - DK
See more reports
Articles of Association
Show latest Articles of Association
Analyses of Exiqon stock
Se analyse fra AktieInfo.net her
Upcoming Events
9 September 2010, CET 17:00-20:15, Copenhagen
Meet Exiqon at the biotech investor event hosted by ProInvestor, IT-Universitetet, Rued Langgaards Vej 7, 2300 Copenhagen S
6 October 2010, Vedbaek, Denmark
Nordea Markets, Healthcare tour for institutional investors
Exiqon Announcements
19 August 2010
Exiqon A/S - Interim report for the period 1 January - 30 June 2010 (unaudited)
20 July 2010
Exiqon A/S - Roche and Exiqon Agree on Joined Marketing Approach for their RT PCR Assay Systems
29 June 2010
Exiqon A/S - Exiqon's Articles of Association as of 29 June 2010
More announcements
Investor Brochures
Exiqon at a glance - UK
PDF 36 KB
Exiqon at a glance - DK
PDF 36 KB
Investor Signup
Signup to receive investor news
Please register your email in Exiqon’s Investor Portal to receive notices convening annual and extraordinary general meetings by email
Register your email by logging on to the
Investor Portal here
Exiqon Presentations
Download Exiqon's latest investor presentations
Exiqon Webcasts
Exiqon's NIM Presentation 2009, May 20, 2009
Webcast presentation of the Exiqon Annual Report 2008, March 3, 2009
Privacy
Sitemap
Legal